J. Dobson

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

S. H. van der Burg, R. Offringa, M. Stanley, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

H. Kitchener, P. Stern, M. Pawlita, 2003, Cancer research.

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine.

S. H. van der Burg, R. Offringa, J. Hickling, 2002, Vaccine.

Versatile mRNA-Nanoparticle Platform for Treatment of Glioblastoma.

A. Grippin, D. Mitchell, E. Sayour, 2021, International journal of radiation oncology, biology, physics.